Identificador persistente para citar o vincular este elemento:
https://accedacris.ulpgc.es/jspui/handle/10553/157542
| Título: | Donation after circulatory death in a European ultraperipheral and multi-insular region | Autores/as: | Groba Marco, María Del Val Fernández De Sanmamed Girón, Miguel Galván Ruíz, Mario Pena Morant, V Romero Lujan, J. L. Gonzalez Martin, J. Portela Torrón, Francisco Antonio Deniz Rosario, J. Acosta Calero,Carmen Rojas Escriva, B. Grillo Perez, J. Belleyo Belkasem, K. Marrero Negrin, N. Caballero Dorta, Eduardo José Garcia Quintana, A. |
Clasificación UNESCO: | 32 Ciencias médicas 320501 Cardiología |
Palabras clave: | Heart transplantation Medical records Ventricular dysfunction Left Brain death, et al. |
Fecha de publicación: | 2025 | Publicación seriada: | European Heart Journal | Conferencia: | ESC Congress 2025 Madrid together with World Congress of Cardiology | Resumen: | Background The creation of a new heart transplant (HT) program in a ultraperipheral region may be limited by a small population and a shortage of cardiac donors. In recent years, controlled donation after circulatory death (DCD) has significantly increased transplant activity. This study aims to evaluate the characteristics and outcomes of DCD using thoraco-abdominal normothermic regional perfusion (TANRP) and static cold storage compared to traditional donation after brain death (DBD) in the XXX HT program. Method We performed a single-center, retrospective observational study of all HT performed between December 2019 and December 2024 in the XXX hospital. Data were obtained from medical records and the XXX HT Registry. Results The first DCD transplant was performed in 2021, and in subsequent years 4 ,7 and 8 HT were procured using this technique (Figure 1A). During the study period, 98 HT were performed and 20% were from DCD. These donors had a similar age compared to DBD donors (49.8 vs. 46.4 years, p = 0.321), were mostly male (80%), and one patient had left ventricular dysfunction during the intraoperative DCD process. Mean waitlist time was shorter in the DCD group (27 vs 66 days, p = 0.03). There were no differences in primary graft dysfunction (10% in the DCD group and 9% in DBD, p = 1) or renal replacement therapy (50% vs 26%, p = 0.055). Median total hospital stay was longer in the DCD group (46 vs 36 days, p = 0.021). In the DCD group, at 1, 6, 12 and 24 months the survival rate was 96%, 95%, 93% and 87%, respectively, with no significant differences compared to the DBD group (Figure 1B). Conclusions In the first HT program in a European ultraperipheral and multi-insular region, DCD is performed safely and effectively without compromising outcomes, and with a significant increase in donor pool. This HT program employed older donors, than those reported in previous studies, with excellent short-term outcomes. Future studies are warranted. | URI: | https://accedacris.ulpgc.es/jspui/handle/10553/157542 | ISSN: | 0195-668X | DOI: | 10.1093/eurheartj/ehaf784.1367 | Fuente: | European Heart Journal[ISSN 0195-668X],v. 46 sup. 1, #ehaf784.1367 (Noviembre 2025) |
| Colección: | Actas de congresos |
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.